Sulfasalazine is a synthetic compound used as an anti-inflammatory drug. It is administered orally to treat inflammatory bowel disease and rheumatoid arthritis. In the intestine the drug is broken down into sulfapyridine and 5-aminosalicylic acid. The sulfapyridine component contributes antibacterial activity that helps reduce bacterial load. The 5-aminosalicylic acid component acts locally to inhibit inflammatory pathways in the gut. Together they suppress immune cell activation and cytokine production, leading to decreased inflammation. The resulting reduction in inflammation alleviates symptoms such as diarrhea, abdominal pain, and joint swelling. By combining these mechanisms the medication provides a dual therapeutic effect that improves disease control.

Sulfasalazine is a synthetic compound used to manage inflammatory conditions of the intestines and joints. It works as a prodrug that is cleaved by gut bacteria into 5-aminosalicylic acid and sulfapyridine in the colon. The released 5-aminosalicylic acid reduces inflammation by inhibiting prostaglandin production and modulating immune cell activity. Sulfapyridine contributes to the systemic immunosuppressive effect by interfering with folate metabolism in immune cells. The combined action decreases immune-mediated tissue damage and alleviates symptoms of ulcerative colitis. Additionally the drug helps control rheumatoid arthritis by suppressing inflammatory pathways in joints. Its antimicrobial property further supports treatment of intestinal infections associated with crohn's disease. Overall Sulfasalazine provides targeted anti-inflammatory therapy through localized conversion and systemic immunosuppression.

Sulfasalazine is used to treat inflammatory bowel disease and arthritis. It can cause gastrointestinal discomfort such as nausea and abdominal pain. Some patients develop skin reactions like rash or itching. Blood cell counts may be affected leading to anemia or low white blood cell numbers. Liver function tests can show elevated enzymes in certain individuals. Rarely visual disturbances such as blurred vision have been reported. Joint pain may occasionally worsen during the early stages of treatment. Monitoring of kidney function is recommended because the drug can increase urinary acidity.

Sulfasalazine is commonly prescribed for inflammatory bowel disease and rheumatoid arthritis. One frequent side effect is gastrointestinal discomfort such as nausea vomiting or abdominal cramps. Some users experience headache or dizziness during treatment. Skin reactions like rash or itching may occur in certain individuals. Rarely the medication can affect liver function leading to abnormal test results. Blood cell counts may be impacted causing fatigue or easy bruising. Visual disturbances including blurred vision have been reported in a small number of cases. Most side effects are mild and often improve with continued use.